Tradestie Institutional Equity Comparison Engine

ACRS vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ACRS trades at N/M Forward P/E with -1412.4% operating margin (-55.1% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, ACRS sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
ACRS N/M vs AVDL 28.8x Fwd P/E
Growth & Margin Winner AVDL
Op Margin -1412.4% vs 2.5% ยท YoY -55.1% vs +54.9%
Momentum & Technical Winner AVDL
1Y +39.8% vs +138.1% ยท 52W Pos 26% vs 89%
Options & Structure Winner AVDL
BREAKDOWN (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
ACRS NASDAQ
Aclaris Therapeutics, Inc.
Pharmaceutical Preparations
$3.44
-1.71% 1D
Market Cap $555.1M
1M Return -10.18%
1Y Return +39.84%
Forward P/E N/M
Unified AI Score
45.2 / 100 HOLD
Tech 42.0 Fund 57.0 Flow 64.0 Mom 70.0
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACRS +39.84% AVDL +138.06% Spread: +44.12 pp (ACRS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACRS TTM Op. Margin: -1412.4% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACRS vs AVDL. Trailing 12-month operating profitability (ACRS -1412.4% vs AVDL 2.5%) and valuation multiples (ACRS N/M vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACRS (0) vs AVDL (9)
Institutional Metric ACRS AVDL Criterion Row Winner
Market Capitalization Scale $555.1M $2.1B Larger Scale AVDL
Trailing P/E Ratio Valuation N/M 16.8x Lower Multiple AVDL
Forward P/E Ratio Valuation N/M 28.8x Lower Multiple AVDL
Revenue Growth (YoY) Growth -55.1% +54.9% Higher Growth AVDL
Operating Margin (TTM) Profitability -1412.4% 2.5% Higher Margin AVDL
Net Profit Margin Profitability 0.0% -0.1% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -55.5% -0.3% Higher ROE AVDL
52-Week Range Position Momentum 26% ($2โ€“$7) 89% ($6โ€“$24) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 69% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 45.2 / 100 (HOLD) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACRS vs AVDL Buy Guide
ACRS BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ACRS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACRS nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.